PharmAla Issues Q2 Financial Statements
Go back to PharmAla Issues Q2 Financial Statements| Medmark Group Inc New (AMEX: MDMA) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.00 | |||
| Open | $0.00 | 52 Week Low | $0.00 | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $0.00 | |||
| Volume | 0 | |||||
| (AMEX: MDXXF) | Delayed: 0.19 +0.02 (11.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.17 | 52 Week High | $ | |||
| Open | $0.17 | 52 Week Low | $ | |||
| Day High | $0.20 | P/E | N/A | |||
| Day Low | $0.17 | EPS | $ | |||
| Volume | 52,477 | |||||
